Literature DB >> 19240827

New evidence on bisphosphonate related osteonecrosis of the jaws suggests dental referral prior to commencement of treatment.

A Kyrgidis, St Triaridis, K Vahtsevanos.   

Abstract

Entities:  

Year:  2009        PMID： 19240827      PMCID： PMC2633260     

Source DB:  PubMed          Journal:  Hippokratia        ISSN： 1108-4189            Impact factor:   0.471


× No keyword cloud information.
  9 in total

1.  Osteonecrosis of the jaw among bisphosphonate users.

Authors:  Athanassios Kyrgidis; Anastassios Barbas
Journal:  Am J Med       Date:  2008-12       Impact factor: 4.965

2.  Clinical characterization might help in preventing osteonecrosis of the jaw.

Authors:  Athanassios Kyrgidis; Charalambos Andreadis
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

Review 3.  Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?

Authors:  Ian R Reid; Mark J Bolland; Andrew B Grey
Journal:  Bone       Date:  2007-05-10       Impact factor: 4.398

4.  Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.

Authors:  Athanassios Kyrgidis; Konstantinos Vahtsevanos; Georgios Koloutsos; Charalampos Andreadis; Ioannis Boukovinas; Zisis Teleioudis; Anna Patrikidou; Stefanos Triaridis
Journal:  J Clin Oncol       Date:  2008-06-23       Impact factor: 44.544

5.  Inhibition of oral mucosal cell wound healing by bisphosphonates.

Authors:  Regina Landesberg; Matthew Cozin; Serge Cremers; Victoria Woo; Stavroula Kousteni; Satrajit Sinha; LeeAnn Garrett-Sinha; Srikala Raghavan
Journal:  J Oral Maxillofac Surg       Date:  2008-05       Impact factor: 1.895

6.  Bax upregulation may provide a rationale for the low incidence of esophageal adenocarcinoma in a Greek cohort of patients with Barrett's esophagus.

Authors:  Dimitrios Chatzopoulos; Athanasios Kyrgidis; Jannis Kountouras; Christos Zavos; Epaminondas Molyvas; Ioannis Venizelos
Journal:  Hepatogastroenterology       Date:  2007 Apr-May

Review 7.  Factors associated with osteonecrosis of the jaw among bisphosphonate users.

Authors:  Lisa M Hess; Joanne M Jeter; Marge Benham-Hutchins; David S Alberts
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

8.  Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.

Authors:  Christian Walter; Bilal Al-Nawas; Knut A Grötz; Christian Thomas; Joachim W Thüroff; Viktoria Zinser; Heinold Gamm; Joachim Beck; Wilfried Wagner
Journal:  Eur Urol       Date:  2008-06-26       Impact factor: 20.096

9.  Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding 'risks and benefits of bisphosphonates'.

Authors:  A Kyrgidis; S Triaridis
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640
  9 in total
  1 in total

1.  The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications.

Authors:  Athanassios Kyrgidis; Thrasivoulos-George Tzellos; Konstantinos Toulis; Konstantinos Antoniades
Journal:  J Osteoporos       Date:  2011-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.